J
Jupiter Neurosciences, Inc. (JUNS)
NCM – Real Time Price. Currency in USD
0.33
-0.01 (-1.78%)
At close: May 12, 2026, 4:00 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NCM – Real Time Price. Currency in USD
0.33
-0.01 (-1.78%)
At close: May 12, 2026, 4:00 PM EDT
No Data
There are no news for this stock.
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 0.65 | 6.05 | 4.0 | |
| Quick ratio | 0.63 | 5.63 | 4.0 | |
| Debt to Equity | N/A | 0.30 | 1.0 | |
| Debt to Assets | 0.96 | 1.04 | 2.0 | |
| Interest coverage | -44.97 | -16.91 | 1.0 | |
| Weighted average score | 2.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | N/A | N/A | N/A | 22K | 22K |
| Gross Profit | N/A | N/A | N/A | 18K | 18K |
| Operating Income | -4M | -4M | -3M | -9M | -9M |
| Net Income | -5M | -5M | -2M | -9M | -9M |
| EBITDA | -4M | -4M | -3M | -9M | -9M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | N/A | 0 | 1.0 |
| Next quarter | N/A | 28.57 | 5.5 |
| Current year | N/A | -225 | 1.0 |
| Next year | -39.35 | -533.33 | 1.0 |
| Weighted average score | 2.1 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | 999 | -12.53 | N/A | -105.11 | 3.3 |
| Y/Y | 999 | -68.55 | N/A | 35.93 | 5.5 |
| 3y average | 999 | -67.27 | N/A | -230.02 | 3.3 |
| 5y average | 999 | -74.73 | N/A | -248.6 | 3.3 |
| Weighted average score | 3.9 | ||||
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |
Total debt $5.3M significantly exceeds cash reserves ($3.8M), raising financial stability concerns
Total current liabilities $7.4M surpass Total current assets $4.8M, signaling liquidity issues
Debt-to-equity ratio (-2.9) is well below the industry average (0.3), showcasing prudent financial management
Interest coverage ratio (-45.0x) is dangerously low, suggesting debt repayment risks
Negative free cash flow -$2.4M limits the company's ability to reinvest or pay down debt